A promising new therapeutic target for prostate cancer has been found by researchers, offering evidence that a newly discovered member of a family of cell surface proteins called G-protein coupled receptors promotes prostate cancer cell growth.
Radiation therapy is the most common treatment for men with prostate cancer regardless of the aggressiveness of the tumor, risk to the patient and overall patient prognosis, researchers have found. These findings lay the groundwork for improved treatment assessment by physicians and to better inform men fighting the disease.
UCLA researchers have found that radiation therapy is the most common treatment for men with prostate cancer regardless of the aggressiveness of the tumor, risk to the patient and overall patient prognosis. These findings lay the groundwork for improved treatment assessment by physicians and to better inform men fighting the disease.
Next generation chemotherapy for prostate cancer has unique properties that could make it more effective earlier in treatment if confirmed in clinical trials, researchers report. Prostate cancer is the second leading cause of cancer for men in the United States. Only one class of chemotherapy called taxanes is currently effective against the disease.
Next generation chemotherapy for prostate cancer has unique properties that could make it more effective earlier in treatment if confirmed in clinical trials.
Lee Hsien Loong expected to recover fully, but questions raised about ruling party's public succession plan.
Both members of a couple can experience diminished sexual function after a man has prostate cancer surgery.
Pom Wonderful LLC has lost its appeal of a Federal Trade Commission decision that ruled its ads violated federal law because they could mislead consumers into stopping prescribed treatments for heart disease, prostate cancer and erectile dysfunction.
A team of scientists has created a "conjugate" molecule -- one stitched together from two separate molecules -- that seeks out and blocks prostate cancer growth in lab animals. The molecule NMI combines a near-infrared dye that targets...Show More Summary
“Often, one biopsy is not enough to definitively rule out prostate cancer,” says study researcher Jonathan Epstein, M.D., director of the Division of Surgical Pathology and a professor of pathology, urology and oncology at the Johns Hopkins University School of Medicine. Show More Summary
Prostate cancer patients with detectable prostate specific antigen (PSA) following radical prostatectomy should receive earlier, more aggressive radiation therapy treatment, according to a study published in the February 1, 2015 issue...Show More Summary
Last week I heard a word for the first time: Bromance. Men United versus Prostate Cancer took another big step towards its twin goals of raising awareness and funds. For two weeks, The Anchor pub on London's South Bank, has turned itself into The Men United Arms and is hosting comedy, quiz and music events [...]
As an indicator of prostate cancer, the PSA test is regarded in urology as highly controversial since it is not always unequivocal. A team of researchers has now developed a program that compensates the shortfalls of PSA screening with methods from personalized medicine. As a result, prostate cancer screening is able to reach a new level of quality.
To help bring a wider array of new prostate cancer therapies to patients sooner, Jefferson joins a prestigious clinical trial group, with several projects already in the works.
Matt Rourke/AP By PETE YOST WASHINGTON -- A federal appeals court said Friday that many advertising claims for POM Wonderful juice were deceptive in asserting that it curbs the risk of heart disease, prostate cancer and erectile dysfunction and is clinically proven to work. In a 3-0 decision, the U.S. Show More Summary
A federal appeals court has upheld a ruling that pomegranate juice seller Pom Wonderful falsely claimed in its advertising that its products could treat heart disease, prostate cancer and erectile dysfunction.
Pomegranate-juice maker Pom Wonderful LLC made false and misleading claims that its products were effective in fighting heart disease and prostate cancer, a federal appeals court ruled on Friday, upholding earlier Federal Trade Commission findings.
Among patients with prostate cancer, those who smoke have increased risks of experiencing side effects from treatment and of developing future cancer recurrences, or even dying from prostate cancer.
Among men undergoing biopsy for suspected prostate cancer, targeted magnetic resonance/ultrasound fusion biopsy, compared with a standard biopsy technique, was associated with increased detection of high-risk prostate cancer and decreased detection of low-risk prostate cancer, according to a study in the January 27 issue of JAMA.
Targeted biopsy using new fusion technology that combines magnetic resonance imaging (MRI) with ultrasound is more effective than standard biopsy in detecting high-risk prostate cancer, according to a large-scale study published today in JAMA.